Day 1 :
Medcare Hospital Sharjah, UAE
Time : 10:00-10:55
Saied Alhabash has obtained his education in Otolaryngology from Damascus Academic Hospitals under the Ministry of High Education supervision and later joined as an Assistant Professor (Demonstrator) in the ENT Department, Almwasat Hospital and Alassad University Hospital. He has worked as a Supervisor in Neurosurgery Department in Damascus Hospital (Endoscopic Skull Base Surgery) and then as Supervisor in ENT Department in Red Crescent Hospital, followed by Mediclinic Beach Road and Welfare Hospital, Canadian specialty Hospital in Dubai, Zulekha Hospital, Sharjah Corniche Hospital and Amina Hospital. Presently, he is working in Medcare Hospital Sharjah, Dubai.
Rush immunotherapy is becoming more popular in the allergy community gradually because of its flexibility and efficacy. We have 2 groups of patients prepared for immunotherapy as we are comparing the compliance of the patient after giving the patient the option of the immunotherapy (the rush versus the standard one). If we removed the insurance issues, the basic compliance of the patient; the basic kit of immunotherapy for the first 3-6 months reaches 90% but the compliance of the standard immunotherapy did not reach 40%. Rush immunotherapy might be very practical way to treat the source of the problem directly even with starting the anti-allergy medication because the compliance rate is high compared to the standard one.